Novartis AG announces strategic review of Novartis India
Novartis India, a listed entiry, is set to undergo an assessment encompassing various aspects, including its parent Novartis AG's 70.68 percent shareholding.
Stay updated with breaking news from Sanjay Murdeshwar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novartis India, a listed entiry, is set to undergo an assessment encompassing various aspects, including its parent Novartis AG's 70.68 percent shareholding.
He has more than 20 years of experience in the healthcare industry.
Sanjay Murdeshwar, the Vice Chairman and Managing Director of Novartis India, has resigned from his position. The board of Novartis India has accepted his resignation, effective from close of business hours on April 2, 2024. Murdeshwar cited the evolution of his personal and professional aspirations as the reason for his resignation.
Novartis to cut up to 8,000 jobs globally as it restructures business
Novartis India Ltd announced that it would transfer the sales and distribution of its products to Dr Reddy’s Laboratories for a few of its established medicines, including the Voveran range, the Calcium range and Methergine.